Clinical Trial Update: Effect of TU-100 on Gastrointestinal and Colonic Transit in Humans [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating TU-100 (Daikenchuto) on gastrointestinal and colonic transit in postoperative ileus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Ileus

Drugs mentioned

• TU-100 (Daikenchuto)

Snippet

Sponsor: Tsumura USA | Conditions: Postoperative Ileus | Phase 1, Phase 2 | Status: COMPLETED